QIAGEN And Incyte Partner To Create New Test For Rare Blood Cancers
15/6 12:39
(RTTNews) - QIAGEN N.V. (QGEN) and Incyte (INCY) announced a collaboration to develop a new diagnostic panel that will support Incyte's experimental therapies for patients with myeloproliferative neoplasms (MPNs), a group of rare blood cancers. This includes Incyte's monoclonal a...